Fmoc-Asp(OtBu)-OH-13C4,15N

Modify Date: 2024-08-06 18:39:31

Fmoc-Asp(OtBu)-OH-13C4,15N structure	Common Name	Fmoc-Asp(OtBu)-OH-13C4,15N
	CAS Number	1160760-08-6	Molecular Weight	416.41
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₉₁₃C₄H₂₅₁₅NO₆	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Fmoc-Asp(OtBu)-OH-13C4,15N

Fmoc-Asp(OtBu)-OH-13C4,15N is the 13C and 15N labeled Fmoc-Asp(OtBu)-OH[1]. Fmoc-Asp(OtBu)-OH (4-tert-Butyl N-(fluoren-9-ylmethoxycarbonyl)-L-aspartate) is a aspartate derivative containing amine protecting group Fmoc. Fmoc-Asp(OtBu)-OH can be used for peptide synthesis[2].

Name	Fmoc-Asp(OtBu)-OH-13C4,15N

Description	Fmoc-Asp(OtBu)-OH-13C4,15N is the 13C and 15N labeled Fmoc-Asp(OtBu)-OH[1]. Fmoc-Asp(OtBu)-OH (4-tert-Butyl N-(fluoren-9-ylmethoxycarbonyl)-L-aspartate) is a aspartate derivative containing amine protecting group Fmoc. Fmoc-Asp(OtBu)-OH can be used for peptide synthesis[2].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Esquivel J B, et al. Chiral HPLC separation of protected amino acids. Journal of liquid chromatography & related technologies, 1998, 21(6): 777-791.

Molecular Formula	C₁₉₁₃C₄H₂₅₁₅NO₆
Molecular Weight	416.41

Fmoc-Asp(OtBu)-OH-13C4,15N

Use of Fmoc-Asp(OtBu)-OH-13C4,15N

Names

Fmoc-Asp(OtBu)-OH-13C4,15N Biological Activity

Chemical & Physical Properties